Export 2409 results:
Author Title [ Type(Asc)] Year
Journal Article
Baptista, S., Piloto, N., Reis, F., Teixeira-De-Lemos, E., et al. (2008). Treadmill running and swimming imposes distinct cardiovascular physiological adaptations in the rat: Focus on serotonergic and sympathetic nervous systems modulation. Acta Physiologica Hungarica, 95(4), 365 - 381.
Ribeiro, C. A., Oliveira, S. M., Guido, L. F., Magalhães, A., et al. (2014). Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model. Journal of Alzheimer's Disease, 39(2), 357 - 370.
Alemi, M., Silva, S. C., Santana, I., & Cardoso, I. (2017). Transthyretin stability is critical in assisting beta amyloid clearance– Relevance of transthyretin stabilization in Alzheimer's disease. CNS Neuroscience and Therapeutics, 23(7), 605 - 619.
Vieira, M., & Saraiva, M. J. (2013). Transthyretin regulates hippocampal 14-3-3ζ protein levels. FEBS Letters, 587(10), 1482 - 1488.
Gomes, J. R., Nogueira, R. S., Vieira, M., Santos, S. D., et al. (2016). Transthyretin provides trophic support via megalin by promoting neurite outgrowth and neuroprotection in cerebral ischemia. Cell Death and Differentiation, 23(11), 1749 - 1764.
Costa, R., Ferreira-Da-Silva, F., Saraiva, M. J., & Cardoso, I. (2008). Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: A mechanism sensitive to the kunitz protease inhibitor. PLoS ONE, 3(8).
Alemi, M., Gaiteiro, C., Ribeiro, C. A., Santos, L. M., et al. (2016). Transthyretin participates in beta-amyloid transport from the brain to the liver- involvement of the low-density lipoprotein receptor-related protein 1?. Scientific Reports, 6.
Ruano, D., Macedo, A., Soares, M. J., Valente, J., et al. (2007). Transthyretin: No association between serum levels or gene variants and schizophrenia. Journal of Psychiatric Research, 41(8), 667 - 672.
Silva, C. S., Eira, J., Ribeiro, C. A., Oliveira, Â., et al. (2017). Transthyretin neuroprotection in Alzheimer's disease is dependent on proteolysis. Neurobiology of Aging, 59, 10 - 14.
Fleming, C. E., Nunes, A. F., & Sousa, M. M. (2009). Transthyretin: More than meets the eye. Progress in Neurobiology, 89(3), 266 - 276.
Nunes, A. F., Saraiva, M. J., & Sousa, M. M. (2006). Transthyretin knockouts are a new mouse model for increased neuropeptide Y. FASEB Journal, 20(1), 166 - 168.
Nunes, A. F., & Sousa, M. M. (2008). Transthyretin knockout mouse nerves have increased lipoprotein lipase and sphingolipid content following crush. Neuroscience Letters, 446(2-3), 83 - 87.
Nunes, A. F., Montero, M., Franquinho, F., Santos, S. D., et al. (2009). Transthyretin knockout mice display decreased susceptibility to AMPA-induced neurodegeneration. Neurochemistry International, 55(7), 454 - 457.
Sousa, J. C., Morreale de Escobar, G., Oliveira, P., Saraiva, M. J., & Palha, J. A. (2005). Transthyretin is not necessary for thyroid hormone metabolism in conditions of increased hormone demand. Journal of Endocrinology, 187(2), 257 - 266.
Sousa, M. M., & Saraiva, M. J. (2008). Transthyretin is not expressed by dorsal root ganglia cells. Experimental Neurology, 214(2), 362 - 365.
Carlos Sousa, J., Grandela, C., Fernández-Ruiz, J., De Miguel, R., et al. (2004). Transthyretin is involved in depression-like behaviour and exploratory activity. Journal of Neurochemistry, 88(5), 1052 - 1058.
Liz, M. A., Leite, S. C., Juliano, L., Saraiva, M. J., et al. (2012). Transthyretin is a metallopeptidase with an inducible active site. Biochemical Journal, 443(3), 769 - 778.
Fleming, C. E., Mar, F. M., Franquinho, F., Saraiva, M. J., & Sousa, M. M. (2009). Transthyretin internalization by sensory neurons is megalin mediated and necessary for its neuritogenic activity. Journal of Neuroscience, 29(10), 3220 - 3232.
Vieira, M., Gomes, J. R., & Saraiva, M. J. (2015). Transthyretin Induces Insulin-like Growth Factor I Nuclear Translocation Regulating Its Levels in the Hippocampus. Molecular Neurobiology, 51(3), 1468 - 1479.
Mar, F. M., Franquinho, F., Fleming, C. E., & Sousa, M. M. (2009). Transthyretin in peripheral nerve regeneration. Future Neurology, 4(6), 723 - 730.
Fleming, C. E., Saraiva, M. J., & Sousa, M. M. (2007). Transthyretin enhances nerve regeneration. Journal of Neurochemistry, 103(2), 831 - 839.
Saraiva, M. J., Magalhaes, J., Ferreira, N., & Almeida, M. R. (2012). Transthyretin deposition in familial amyloidotic polyneuropathy. Current Medicinal Chemistry, 19(15), 2304 - 2311.
Ribeiro, C. A., Santana, I., Oliveira, C., Baldeiras, I., et al. (2012). Transthyretin decrease in plasma of MCI and AD patients: Investigation of mechanisms for disease modulation. Current Alzheimer Research, 9(8), 881 - 889.
Ferreira, N., Pereira-Henriques, A., & Almeida, M. R. (2015). Transthyretin chemical chaperoning by flavonoids: Structure-activity insights towards the design of potent amyloidosis inhibitors. Biochemistry and Biophysics Reports, 3, 123 - 133.
Costa, R., Gonçalves, A., Saraiva, M. J., & Cardoso, I. (2008). Transthyretin binding to A-Beta peptide - Impact on A-Beta fibrillogenesis and toxicity. FEBS Letters, 582(6), 936 - 942.


Home | Site Map | Contacts | Credits | Privacy & Cookies | Intranet | Social Networks |

rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 220 408 800 | email: info@ibmc.up.pt | © copyright 2010 ibmc